Released Presentations
PLENARY SESSIONS
ISSUE PANEL PRESENTATIONS

IP1 : VALUE FRAMEWORKS: IS IT POSSIBLE TO ESTABLISH IN LATIN AMERICA? (Invited Issue Panel)

Presentation
Lou Garrison, Professor, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA
Presentation
Aurelio Mejia, Senior Economist, Health Technology Assessment, Instituto de Evaluación Tecnológica en Salud, Bogotá, Colombia
Presentation
Rafael Alfonso Cristancho, Lead Analytics and Innovation, Value Evidence and Outcomes, GSK, Collgeville, PA, USA

 

IP2 : DADOS DO MUNDO REAL (RWD) PARA O APOIO AO DESENVOLVIMENTO DE POLITICAS DE SAUDE E À UTILIZAÇÃO PONDERADA DE BIOLÓGICOS E BIOSSIMILARES NA AMÉRICA LATINA: O QUE APRENDEMOS COM O PASSADO E COMO ESTÁ A MOLDAR O FUTURO?

Presentation
Andreia Ribeiro, Engagement Manager, Market Access and P&R Practice, Lifescience Dynamics, Boston, MA, USA
Ricardo Garcia, Director, CLAPBio, Latin American Research Center of Biotechnology, Rio de Janeiro, Brazil
Lindemberg Assuncao, Chief of Therapeutic Sector at EBSERH, Complexo Hospitalar Universitário Prof. Edgard Santos, Salvador BA, Brazil
Fabricio Collares, Regional Medical Director LATAM, EMD Serono, Miami, FL, USA

 

IP3 : LOS DESAFIOS DE LAS ENFERMEDADES RARAS EN LA REGIÓN: EQUILIBRIO ENTRE EL ACCESO Y ACCESIBILIDAD (Invited Issue Panel)

Presentation
Diego Rosselli, Profesor Adjunto, Economía de la Salud, Pontificia Universidad Javeriana, Bogotá, Colombia
Presentation
Angela Chaves, Presidente, Federación Colombiana de Enfermedades Raras, Bogotá, Colombia

 

IP4 : COST-EFFECTIVENESS THRESHOLDS IN LATIN AMERICA: WHAT CAN WE LEARN FROM REGIONAL AND INTERNATIONAL EXPERIENCES? (Invited Issue Panel)

Presentation
Vania Cristina Canuto Santos, Deputy Director, Department of Management and Incorporation of Health Technology – DGITS, CONITEC, Brazilian Ministry of Health, Brasília, Brazil
Presentation
Lou Garrison, Professor, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA
Presentation
Andres Pichon-Riviere, Director, Health Technology Assessment and Economic Evaluation, Institute for Clinical Effectiveness and Health Policy (IECS), CABA, Argentina
Presentation
Hector Castro, Director of Drugs Incorporation, Colombian Ministry of Health, Bogota, Colombia

 

IP5 : DESAFIOS NOS SISTEMAS DE SAÚDE DA AMÉRICA LATINA: QUAIS EVIDÊNCIAS DE MUNDO REAL SÃO NECESSÁRIAS PARA ESTIMAR VALOR DE EQUIPAMENTOS MÉDICO-ASSISTENCIAIS E TESTES DIAGNÓSTICOS EM UM PROCESSO DE AVALIAÇÃO DE TECNOLOGIAS EM SAÚDE?

Presentation
Cristina Nunes Ferreira, Sr. Manager, Reimbursement & Health Economics for LATAM, Edwards Lifesciences Latam, São Paulo, Brazil

 

IP6 : TECHNOLOGY ENABLED PATIENT ADHERENCE PROGRAMS AS A SOURCE OF REAL-WORLD EVIDENCE: OPPORTUNITIES IN LATIN AMERICA

Presentation
Miguel Martin de Bustamante, Senior Associate, CBPartners, San Francisco, CA, USA
Diego F Guarin, Senior Director, HEOR & HTA Strategy, HEOR & HTA, Latin America, Merck-Serono, Billerica, MA, USA
Sandeep Duttagupta, Vice President, CBPartners, New York, NY, USA

 

IP7 : RISK SHARING AGREEMENTS: PERSPECTIVES AND CHALLENGES FOR THEIR IMPLEMENTATION IN LATIN AMERICA: A MULTI-STAKEHOLDERS DEBATE

Presentation
Louis Garrison, Interim Director, PORPP, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA
Presentation
Rony Lenz Alcayaga, Profesor Asistente, Escuela de Salud Pública, Universidad de Chile y Consultor Principal, Lenz Consultores, Santiago, Chile
Presentation
Daniela Paredes Fernandez, Assistant Professor, Departamento Promoción de la Salud de la Mujer y el Recién Nacido, Universidad de Chile, Santiago, Chile
Presentation
Diego F Guarin, Senior Director, HEOR & HTA Strategy, HEOR & HTA, Latin America, Merck-Serono, Billerica, MA, USA

 

IP8 : EL CONCEPTO DE VALOR

Presentation
Diego Rosselli, Profesor Adjunto, Economía de la Salud, Pontificia Universidad Javeriana, Bogotá, Colombia
Presentation
Angela Chaves, Presidente, Federación Colombiana de Enfermedades Raras, Bogotá, Colombia
Presentation
Jaime Calderón, Director Ejecutivo, Instituto de Evaluación Tecnológica en Salud, Bogotá, Colombia

 

IP9 : ANÁLISE DE DECISÃO MULTI-CRITÉRIOS (MCDA) NA AMÉRICA LATINA (Invited Issue Panel)

Presentation
Martina Garau, Senior Economist, Office of Health Economics, London, UK
J. Jaime Caro, Chief Scientist, Evidera, Waltham, MA, USA
Laura Murta Amaral, Project manager, SENSE Company, RJ, Brazil
Joice Valentim, Latin America HTA & Reimbursement Policy Lead, Roche Pharma, LA, São Paulo, Brazil

 

IP10 : ESQUEMAS DE PRECIO BASADOS EN EL VALOR... ¿SEGURO QUE NO ES SUEÑO?

Presentation
Ramiro E. Gilardino, Director, Global Networks Latin America, International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Lawrenceville, NJ, USA
Presentation
Lucas Najun Dubos, Access Planning & HEOR Manager, Roche Argentina, Buenos Aires, Argentina
Presentation
German De La llave, Medical Head, ASE MEDIFE, Buenos Aires, Argentina
Presentation
Diego Lencina, Director, Azistia, Buenos Aires, Argentina

 

IP11 : LIMIAR DE DISPOSIÇÃO A PAGAR NO BRASIL: POSSÍVEIS CAMINHOS

Presentation
Alexander Itria, HEAD, HEALTH ECONOMY, GOIAS UNIVERSITY, goiânia, Brazil
Presentation
Everton Nunes Silva, Professor, Public Health, University of Brasilia, Brasília, Brazil
Presentation
Rodrigo Antonini Ribeiro, Managing Partner and Researcher, HTAnalyze and IATS, Porto Alegre, Brazil

 

IP12 : REAL WORLD STUDIES AND PUBLIC HEALTH POLICIES IN EMERGING MARKETS: NEEDS AND CHALLENGES

Presentation
Diego Novick, Research Advisor, Global Patient Outcomes and Real Wold Evidence, Eli Lilly and Company, Windlesham, Surrey, UK
Presentation
Guilherme Silva Julian, Clinical Research Specialist, Evidências - Kantar Health, São Paulo, Brazil
Presentation
Alexandre Dias Porto Chiavegatto Filho, Professor, Public Health, Universidade de São Paulo, São Paulo, Brazil

 

IP13 : O PAPEL DOS TESTES DIAGNÓSTICOS EM POLÍTICA PÚBLICA DE SAÚDE E EM DECISÕES CLÍNICAS: O ATUAL MODELO DE ATS É EFICIENTE?

Presentation
Charles V. Cachoeira, Global Director Market Access, Roche Diagnostics, Tucson, AZ, USA
Presentation
Esteban Lifschitz, Director, Carrera de Médico Especialista en Evaluación de Tecnologías Sanitarias, Facultad de Medicina, Universidad de Buenos Aires (UBA), Buenos Aires, Argentina
Presentation
Murilo Contó, National Consultant of Health Technology Assessment and Management, PAHO/WHO, Brasília, Brazil

 

IP14 : NOVOS MODELOS DE REEMBOLSO NA SAÚDE: FOCO EM SAÚDE BASEADA EM VALOR (VALUE-BASED CARE)

Presentation
Wilson Follador, Managing Partner, TechValue Healthcare Consulting, São Paulo, Brazil
Presentation
Cesar Luiz Lacerda Abicalaffe, CEO, 2iM Inteligência Medica S/A, Curitiba, Brazil
Presentation
Marcelo Katz, Senior Researcher, Value Management Office, Hospital Israelita Albert Einstein, Sao Paulo, Brazil

 

WORKSHOP PRESENTATIONS

W1 : MÉTODOS EM EVOLUÇÃO PARA A GERAÇÃO DE EVIDÊNCIAS DE MUNDO REAL EM MERCADOS MADUROS E EMERGENTES

Presentation
David Thompson, Senior Vice President, Real-World Evidence & Insights, inVentiv Health, Princeton, NJ, USA

 

W2 : APPROACHES FOR PRIORITY SETTING: IS THERE A BEST WAY?

Presentation
Manuel A. Espinoza, Profesor, Departamento de Salud Pública y Jefe, Unidad de Evaluaciones de Tecnologías Sanitarias - Centro de Investigación Clínica, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile, e Investigador Visitante Honorario, Centro para la Economía de Salud, Universidad de York, York, UK
Presentation
Aurelio Mejia, Senior Economist, Health Technology Assessment, Instituto de Evaluación Tecnológica en Salud, Bogotá, Colombia

 

W4 : INCORPORACIÓN DE REPRESENTANTES DE PACIENTES EN PROCESOS DE DECISIÓN DE COBERTURA EN SALUD: AVANCES Y DESAFÍOS PARA LATINOAMÉRICA

Presentation
Báltica Cabieses, Profesora, Facultad de Medicina - Clínica Alemana, Universidad del Desarrollo, Santiago, Chile
Presentation
Manuel A. Espinoza, Professor, Department of Public Health & Chief, Unit of Health Technology Assessment - Center for Clinical Research, Catholic University of Chile, Santiago, Chile and Honorary Visiting Fellow, Centre for Health Economics, University of York, York, UK
Presentation
Cecilia Rodriguez, Directora, Fundación Me Muevo, Santiago, Chile

 

W5 : AVALIAÇÃO DE VALOR EM MEDICAL DEVICES NA PERSPECTIVA LATINO AMERICANA (Invited Workshop)

Presentation
Silvio Mauro Junqueira Junior, Health Economics & Market Access Senior Manager, Health Economics, Johnson & Johnson Medical Brazil, São Paulo, Brazil
Presentation
Ramiro E. Gilardino, Director, Global Networks Latin America, International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Lawrenceville, NJ, USA
Presentation
Lucila Rey-Ares, Lead, Health Technology and Audit Committee, CEMIC, Buenos Aires, Argentina
Presentation
Marcelo Katz, Senior Researcher, Value Management Office, Hospital Israelita Albert Einstein, Sao Paulo, Brazil

 

W6 : EXPERIENCIA DE TRABAJO COLABORATIVO ENTRE PAISES DE AMÉRICA LATINA PARA LA TOMA DE DECISIONES INFORMADAS DE MEDICAMENTOS: PROYECTO DIME

Presentation
Constanza Vargas, HTA Research Coordinator, Centro de Investigacion Clinica UC, Pontificia Universidad Catolica de Chile, Santiago, Chile
Ana Lucía Muñoz Mejía, Especialista Sénior de Protección Social, Proyecto Regional sobre Priorización y Planes de Beneficios en Salud, Banco Interamericano de Desarrollo, Bogotá, Colombia
Rosa María Galindo-Suárez, Deputy General Director of Prioritization, General Health Council, Ministry of Health, Mexico City, Mexico
Claudia Vaca, Directora Tecnica Proyecto DIME/Profesor Asistente, Universidad Nacional de Colombia, Bogota, Colombia
Hernando Gaitán, Professor, Departamento de Obstetricia y Ginecología, Universidad Nacional de Colombia, Bogota, Colombia

 

W8 : USO DE LA EVIDENCIA DEL MUNDO REAL (RWE) EN LA TOMA DE DECISIONES EN SALUD: LOS CASOS DE ARGENTINA, CHILE Y COLOMBIA

Presentation
Sebastian Garcia, Coordinator, Departamento Evaluación de Tecnologías Sanitarias y Evaluaciones Económicas, IECS, Buenos Aires, Argentina
Presentation
Manuel A. Espinoza, Profesor, Departamento de Salud Pública y Jefe, Unidad de Evaluaciones de Tecnologías Sanitarias - Centro de Investigación Clínica, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile, e Investigador Visitante Honorario, Centro para la Economía de Salud, Universidad de York, York, UK
Presentation
Diego Rosselli, Profesor Adjunto, Economía de la Salud, Pontificia Universidad Javeriana, Bogotá, Colombia
Presentation
Nahila Justo, Scientific Director, Mapi Sweden AB and Karolinska Institute, NVS department, Stockholm, Sweden

 

W9 : RECENT EXPERIENCES USING THE EUROQOL EQ-5D INSTRUMENT IN LATIN AMERICA: THE 3L&5L; PUBLIC HEALTH AND ECONOMIC EVALUATIONS; NEWER TIME TRADE OFF VARIANTS AND DISCRETE CHOICE EXPERIMENTS

Presentation
Henry H. Bailey, Lecturer, Arthur Lok Jack Graduate School of Business and the Centre for Health Economics, The University of the West Indies, Mt. Hope, Trinidad and Tobago
Presentation
Victor Zarate, Investigador, Departamento de Evaluación de Tecnologías Sanitarias, Ministerio de Salud de Chile, e Investigador, Escuela de Medicina, Universidad de los Andes, Santiago, Chile
Presentation
Federico Augustovski, Director, Departamento de Evaluaciones Económicas y de Tecnologías Sanitarias, Instituto de Efectividad Clínica y Sanitaria (IECS), y Profesor de Salud Pública, Universidad de Buenos Aires, Buenos Aires, Argentina

 

W10 : HEALTH ECONOMICS AND OUTCOMES RESEARCH NEEDS ASSESSMENT FOR LATIN AMERICA: RELATIONSHIP BETWEEN PERCEIVED AND EXPECTED QUALITY OF KNOWLEDGE IN A SELF-ASSESSMENT SURVEY (Invited Workshop)

Presentation
Iris Contreras, Investigadora Asociada, Hospital General de Zona 1A Venados, Instituto Mexicano del Seguro Social, Mexico D.F., Mexico
Presentation
Andre Ferreira Azeredo-da-Silva, Internal Medicine Physician, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil

 

ISPOR FORUMS

F1 : REGULATION IN HEALTH SYSTEMS AND EQUITY: LESSONS LEARNED AND FUTURE PERSPECTIVES FROM AN INEQUITABLE REGION IN THE WORLD

Presentation
Presentation
Raquel Medeiros Lisbôa, General Manager, Healthcare Regulation, Agencia Nacional de Saude Complementar, Rio de Janeiro, Brazil
Presentation
Baltica Cabieses, Social Epidemiologist, Programa de Estudios Sociales en Salud, Instituto de Ciencias e Innovacion en Medicina, Universidad del Desarrollo, Santiago, Chile
Presentation
Edward M.A. Mezones-Holguín, Jefe, Escuela de Postgrado, Universidad San Ignacio de Loyola, Lima, Peru

 

F2 : DATOS Y EVIDENCIAS DEL MUNDO REAL EN LATINOAMÉRICA: ¿REALIDAD O FICCIÓN?

Presentation
Federico Augustovski, Director, Departamento de Evaluaciones Económicas y de Tecnologías Sanitarias, Instituto de Efectividad Clínica y Sanitaria (IECS), y Profesor de Salud Pública, Universidad de Buenos Aires, Buenos Aires, Argentina
Presentation
Gerardo Machnicki, Director, Real World Evidence LATAM, Janssen, Buenos Aires, Argentina
Presentation
Mariana Glancszpigel, Directora, 3Eff S.A., Buenos Aires, Argentina
Presentation
Natalia Jorgensen, Advisor, Ministry of Health, Buenos Aires, Argentina

 

F3 : ADAPTIVE PATHWAYS AND PATIENT ACCESS – IS THERE A PLACE FOR NEW PAYMENT MODELS?

Presentation
Marcelo Fonseca, Professor, Federal University of São Paulo, São Paulo, Brazil
Presentation
Rosa Maria Galindo Suarez, Deputy General Director of Prioritization, General Health Council, Mexico City, Mexico
Presentation
Finn Børlum Kristensen, Professor, Faculty of Health Sciences, University of Southern Denmark, Hilleroed, Denmark
Presentation
Diego F Guarin, Senior Director, HEOR & HTA Strategy, HEOR & HTA, Latin America, Merck-Serono, Billerica, MA, USA

 

EDUCATIONAL SYMPOSIA

NEW DATA SOURCES AND PARTNERSHIP OPPORTUNITIES IN BRAZIL: UNDERSTANDING MARKETS, GAPS IN CARE AND IMPROVING THE SYSTEM

Presentation
Henry Sznejder, Director, Health Information and Planning, AMIL / United Health Group, Sao Paulo, Brazil
Daniel Coldry, Director of Clinical Systems, Amil, Rio de Janeiro, Brazil
Presentation
Bruno Scarpellini, Regional RWE Manager, Latin America, Janssen Pharmaceuticals, São Paulo, Brazil

 

SUSTAINABILITY OF VACCINATION PROGRAMS IN LATIN AMERICA: NEW APPROACHES AVAILABLE UNDER GOVERNMENT BUDGET RESTRICTIONS

Presentation
Jorge Gomez, Health Economy Manager, GSK, Victoria, Argentina
Presentation
Rodrigo DeAntonio, Director Epidemiology and Health Outcome, GSK, Panama City, Panama
Presentation
Baudouin Standaert, Director, Health Economics, GSK, Wavre, Belgium

 

PODIUM AND POSTER PRESENTATIONS


For contributed research podium and poster abstracts and released slide or poster presentations for the ISPOR 6th Latin America Conference, see: the ISPOR Scientific Presentations Database an electronic database of nearly 39,500 research papers presented at ISPOR Annual International Meetings, ISPOR Annual European Congresses, and biennial ISPOR Asia-Pacific & Latin America Conferences from 1998 to date.

  • ISPOR Scientific Presentations Database
  • Under Meeting select ISPOR 6th Latin America Conference – São Paulo, Brazil
  • Select Search for all research podium and poster abstracts and available slide or poster presentations from the meeting. Alternatively search by disease/disorder, topic or subtopic.
OPEN MEETINGS
EDUCATIONAL FORUM
STUDENT SHOWCASE
Contact ISPOR @ info@ispor.org | View Legal Disclaimer
© 2018 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.